Try Fund Library Premium
For Free with a 30 day trial!
Sector: Real Estate
|
Close (12-12-2025) |
$18.67 |
|---|---|
| Change |
$0.13
(0.70%)
|
| Volume | 2,440,771 |
| Open | $18.62 |
|---|---|
| Day Range | $18.44 - $18.86 |
| 52 Week Low | $12.48 |
| 52 Week High | $21.80 |
| Annual Yield | 2.73% |
|---|---|
| Annual Dividend | $0.51 |
| Last Dividend (09-09-2025) | $0.17 |
| Industry Sector | Real Estate |
|---|---|
| Quoted Market Value | $4,781,724,628 |
| Shares Outstanding | 256,118,084 |
| Book Value per Share | $1.91 |
| Earnings per Share | -$1.65 |
| Date | Close | Change |
|---|---|---|
| December 12, 2025 | 18.67 |
$0.13
(0.70%)
|
| December 11, 2025 | 18.54 |
$0.47
(2.60%)
|
| December 10, 2025 | 18.07 |
$0.39
(2.21%)
|
| December 09, 2025 | 17.68 |
$0.28
(1.61%)
|
| December 08, 2025 | 17.40 |
-$0.35
(-1.97%)
|
| December 05, 2025 | 17.75 |
$0.39
(2.25%)
|
| December 04, 2025 | 17.36 |
-$0.08
(-0.46%)
|
| December 03, 2025 | 17.44 |
$0.34
(1.99%)
|
| December 02, 2025 | 17.10 |
-$0.26
(-1.50%)
|
| December 01, 2025 | 17.36 |
$0.00
(0.00%)
|
| November 28, 2025 | 17.36 |
$0.12
(0.70%)
|
| November 27, 2025 | 17.24 |
$0.00
(0.00%)
|
| November 26, 2025 | 17.24 |
$0.23
(1.35%)
|
| November 25, 2025 | 17.01 |
$0.49
(2.97%)
|
| November 24, 2025 | 16.52 |
-$0.07
(-0.42%)
|
| November 21, 2025 | 16.59 |
$0.39
(2.41%)
|
| November 20, 2025 | 16.20 |
-$0.02
(-0.12%)
|
| November 19, 2025 | 16.22 |
-$0.38
(-2.29%)
|
| November 18, 2025 | 16.60 |
$0.03
(0.18%)
|
| November 17, 2025 | 16.57 |
-$0.64
(-3.72%)
|
| November 14, 2025 | 17.21 |
-$0.06
(-0.35%)
|
| November 13, 2025 | 17.27 |
-$0.27
(-1.54%)
|
| November 12, 2025 | 17.54 |
-$0.40
(-2.23%)
|
| November 11, 2025 | 17.94 |
$0.06
(0.34%)
|
| November 10, 2025 | 17.88 |
-$0.14
(-0.78%)
|
| November 07, 2025 | 18.02 |
$0.62
(3.56%)
|
| November 06, 2025 | 17.40 |
-$0.27
(-1.53%)
|
| November 05, 2025 | 17.67 |
-$0.03
(-0.17%)
|
| November 04, 2025 | 17.70 |
$0.36
(2.08%)
|
| November 03, 2025 | 17.34 |
$0.19
(1.11%)
|
Try Fund Library Premium
For Free with a 30 day trial!